Epidemiology of norovirus and viral gastroenteritis in Ontario, Canada, 2009-2014.
Canada
Ontario
acute gastroenteritis
norovirus
surveillance
viral gastroenteritis
Journal
Canada communicable disease report = Releve des maladies transmissibles au Canada
ISSN: 1188-4169
Titre abrégé: Can Commun Dis Rep
Pays: Canada
ID NLM: 9303729
Informations de publication
Date de publication:
14 Oct 2021
14 Oct 2021
Historique:
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
6
11
2021
Statut:
epublish
Résumé
Norovirus is the most common cause of acute gastroenteritis in Canada. The illness causes great morbidity and high societal costs. The objective of this article is to describe the epidemiology of norovirus in the province of Ontario, Canada from 2009 to 2014. To assess activity of norovirus and viral gastroenteritis (VGE) in Ontario, three datasets were acquired from the provincial government: two traditional surveillance datasets (outbreak and laboratory) and syndromic surveillance data (telehealth), all spanning 2009-2014. All outbreaks, laboratory submissions and telehealth calls were first assessed for total VGE. Norovirus and norovirus-like illness totals were calculated as a proportion of VGE to estimate agent-specific activity levels. Affected institution types, sexes and age groups were also analyzed. Between 2009 and 2014, 41.5% of VGE outbreaks, 63.4% of VGE laboratory submissions and 36.6% of all acute gastroenteritis-related (not restricted to viral causes) telehealth calls were attributed to norovirus and norovirus-like illness in Ontario. The most commonly affected institution type was long-term care homes and the most commonly affected age groups were younger (younger than five years) and older (older than 65 years) individuals. Females were slightly more frequently affected than males. Norovirus and norovirus-like illnesses were the leading cause of VGE in Ontario between 2009 and 2014. They comprised the greatest percentage of VGE when compared with all other VGE-associated viruses. Additional work is needed to determine all component costs and necessary public health actions to reduce the burden of disease.
Sections du résumé
BACKGROUND
BACKGROUND
Norovirus is the most common cause of acute gastroenteritis in Canada. The illness causes great morbidity and high societal costs. The objective of this article is to describe the epidemiology of norovirus in the province of Ontario, Canada from 2009 to 2014.
METHODS
METHODS
To assess activity of norovirus and viral gastroenteritis (VGE) in Ontario, three datasets were acquired from the provincial government: two traditional surveillance datasets (outbreak and laboratory) and syndromic surveillance data (telehealth), all spanning 2009-2014. All outbreaks, laboratory submissions and telehealth calls were first assessed for total VGE. Norovirus and norovirus-like illness totals were calculated as a proportion of VGE to estimate agent-specific activity levels. Affected institution types, sexes and age groups were also analyzed.
RESULTS
RESULTS
Between 2009 and 2014, 41.5% of VGE outbreaks, 63.4% of VGE laboratory submissions and 36.6% of all acute gastroenteritis-related (not restricted to viral causes) telehealth calls were attributed to norovirus and norovirus-like illness in Ontario. The most commonly affected institution type was long-term care homes and the most commonly affected age groups were younger (younger than five years) and older (older than 65 years) individuals. Females were slightly more frequently affected than males.
CONCLUSION
CONCLUSIONS
Norovirus and norovirus-like illnesses were the leading cause of VGE in Ontario between 2009 and 2014. They comprised the greatest percentage of VGE when compared with all other VGE-associated viruses. Additional work is needed to determine all component costs and necessary public health actions to reduce the burden of disease.
Identifiants
pubmed: 34737671
doi: 10.14745/ccdr.v47i10a01
pii: 471001
pmc: PMC8525908
doi:
Types de publication
Journal Article
Langues
eng
Pagination
397-404Déclaration de conflit d'intérêts
Competing interests: None.Funding: This work was supported by the University of Guelph.
Références
Emerg Infect Dis. 2011 Aug;17(8):1381-8
pubmed: 21801613
Foodborne Pathog Dis. 2013 Jul;10(7):639-48
pubmed: 23659355
J Pediatric Infect Dis Soc. 2013 Mar;2(1):61-2
pubmed: 26619443
Emerg Infect Dis. 2013 Aug;19(8):1198-205
pubmed: 23876403
J Gen Virol. 2015 Sep;96(9):2919-2927
pubmed: 26025873
J Infect Dis. 2021 Feb 13;223(3):452-461
pubmed: 32614406
J Med Virol. 2008 Aug;80(8):1468-76
pubmed: 18551613
Clin Infect Dis. 2021 Oct 20;73(8):1414-1423
pubmed: 33993272
Emerg Infect Dis. 2011 Aug;17(8):1516-8
pubmed: 21801639
Clin Infect Dis. 2015 Jul 1;61(1):77-85
pubmed: 25828997
Clin Infect Dis. 2021 Aug 16;73(4):e913-e920
pubmed: 34398953
J Virol. 2015 Jun;89(11):5756-9
pubmed: 25787285
Clin Infect Dis. 2008 Nov 1;47(9):1202-8
pubmed: 18808354
J Clin Virol. 2009 Jan;44(1):1-8
pubmed: 19084472
J Infect Dis. 2013 Apr;207(7):1058-65
pubmed: 23300161
Rev Inst Med Trop Sao Paulo. 2010 Sep-Oct;52(5):237-42
pubmed: 21049226
Epidemiol Infect. 2015 Dec;143(16):3528-37
pubmed: 25991407
Gut. 2012 Jan;61(1):69-77
pubmed: 21708822
Front Immunol. 2020 Jul 07;11:1383
pubmed: 32733458
PLoS One. 2016 May 11;11(5):e0154340
pubmed: 27168335
Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2371-2379
pubmed: 31502119
PLoS One. 2014 Feb 13;9(2):e88978
pubmed: 24551201
Vaccine. 2017 Jan 23;35(4):680-686
pubmed: 28007397
Viruses. 2010 Mar;2(3):748-81
pubmed: 21994656
N Engl J Med. 2009 Oct 29;361(18):1776-85
pubmed: 19864676
Clin Infect Dis. 2011 Sep;53(6):568-71
pubmed: 21832262
Ann Intern Med. 1982 Jun;96(6 Pt 1):756-61
pubmed: 6283977
N Engl J Med. 2010 Feb 11;362(6):557; author reply 557-8
pubmed: 20147725
J Hosp Infect. 2010 Apr;74(4):385-93
pubmed: 20172625